Schedule 13G ownership disclosure

LAKEFRONT BIOTHERAPEUTICS NV

Security class unavailable · CUSIP: 36315X101

Event date: 2019-07-15

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
5,792,737
Percent of class
10.6000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-19-040709
Form type
SC 13G/A
Filer
Lakefront Biotherapeutics NV
CIK
CIK 1421876
Filed
Jul 17, 2019
Reporting period
Jul 15, 2019
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub